0001437749-25-000739.txt : 20250108 0001437749-25-000739.hdr.sgml : 20250108 20250108163758 ACCESSION NUMBER: 0001437749-25-000739 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250108 DATE AS OF CHANGE: 20250108 EFFECTIVENESS DATE: 20250108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Luminary Therapeutics, Inc. CENTRAL INDEX KEY: 0001793860 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-534624 FILM NUMBER: 25518999 BUSINESS ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 BUSINESS PHONE: 612-309-7653 MAIL ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 D 1 primary_doc.xml X0708 D LIVE 0001793860 Luminary Therapeutics, Inc. 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 612-309-7653 DELAWARE None None Corporation true Jeff Liter 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Executive Officer Director Promoter John Wells 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director James Haymaker 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Promoter Tracey Lodie 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Mark Chance 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Jeff Ross 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Biotechnology Decline to Disclose 06b false 2024-11-20 false true false 0 5920000 5184500 735500 13(a) and 13(b) include the conversion of previously issued Simple Agreements for Future Equity (SAFEs). false 48 0 0 0 false Luminary Therapeutics, Inc. /s/ Jeff Liter Jeff Liter President and Chief Executive Officer 2025-01-08